Main > GENETIC DISEASES (*) > Tyrosinemia Type 1 * > Treatment > Co: SE. S. Nitisinone Cap. > (*) CA Approval Date: 2017. 11.27>

---

(*) CA Approval Date: 2017. 11.27>'s subsections
>oral suspension formulation

(*) CA Approval Date: 2017. 11.27>'s products
This section has no products